Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TriSalus Life Sciences (TLSI) Total Non-Current Liabilities (2022 - 2025)

Historic Total Non-Current Liabilities for TriSalus Life Sciences (TLSI) over the last 4 years, with Q3 2025 value amounting to $50.4 million.

  • TriSalus Life Sciences' Total Non-Current Liabilities rose 2569.89% to $50.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $50.4 million, marking a year-over-year increase of 2569.89%. This contributed to the annual value of $41.5 million for FY2024, which is 2578.79% up from last year.
  • As of Q3 2025, TriSalus Life Sciences' Total Non-Current Liabilities stood at $50.4 million, which was up 2569.89% from $50.7 million recorded in Q2 2025.
  • Over the past 5 years, TriSalus Life Sciences' Total Non-Current Liabilities peaked at $53.5 million during Q1 2025, and registered a low of $16.0 million during Q3 2023.
  • For the 4-year period, TriSalus Life Sciences' Total Non-Current Liabilities averaged around $39.4 million, with its median value being $40.8 million (2024).
  • In the last 5 years, TriSalus Life Sciences' Total Non-Current Liabilities plummeted by 270.69% in 2023 and then skyrocketed by 14993.14% in 2024.
  • TriSalus Life Sciences' Total Non-Current Liabilities (Quarter) stood at $33.9 million in 2022, then decreased by 2.71% to $33.0 million in 2023, then increased by 25.79% to $41.5 million in 2024, then increased by 21.31% to $50.4 million in 2025.
  • Its Total Non-Current Liabilities was $50.4 million in Q3 2025, compared to $50.7 million in Q2 2025 and $53.5 million in Q1 2025.